|
|
||||||||

,
,¶
* Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan;
Laboratory of Developmental Immunology, Graduate School of Frontier Biosciences; Department of Molecular Oncology, Graduate School of Medicine, Osaka University, Suita, Japan;
Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan;
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and
¶ Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kawaguchi, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Dendritic cells (DCs) are major APCs essential for the activation of naive T cells and the initiation of immune responses (6). Moreover, it was reported that DCs in the thymus (thymic DCs) might play a key role for depletion of autoreactive T cells (7). While it was initially considered that DCs were generated from myeloid progenitors, it was later shown that thymic DCs are de-rived from intrathymic lymphoid progenitors, common precursors of T and NK cells (8, 9). Macrophages are present in various tissues including the thymus and phagocytose microbes and apoptotic cells. Because a vast majority of T cells are depleted during T cell selection, thymic macrophages are suggested to be scavengers for apoptotic thymocytes (10, 11). Although macrophages are generated from myeloid progenitors, it was also reported that macrophages in the lymph node might be derived from lymphoid progenitors (12), and thymocytes could differentiate into macrophages in vitro (13, 14).
Thymic epithelial cells (TECs) are involved in the T cell selection by the direct interaction with thymocytes and are composed of two major subsets, cortical and medullary epithelia, which are distinguished by the expression of keratin 8 and keratin 5, respectively (15). It was recently reported that the interaction of thymocytes with TECs is important for the differentiation of TECs. Thymocytes regulate TECs to build up the thymic architecture, resulting in the formation of cortical microenvironments followed by the establishment of medullary microenvironments (15, 16). Although heterogeneity of TECs has been recognized, little is known about the nature of each subpopulation of TECs.
T cell development is also supported by cytokines produced from thymic stromal cells. TECs support T cell development by production of cytokines and chemokines that regulate the proliferation and migration of thymocytes in a differentiation-dependent manner (17). T cell progenitors and other lymphoid progenitors require IL-7 for their survival and proliferation (18, 19). Oncostatin M (OSM) is a member of the IL-6 family of cytokines and its receptor consists of the OSM specific receptor subunit (OSMR
) and gp130, the common receptor subunit of this cytokine family. It was reported that OSM is expressed in CD45-positive hemopoietic cells, whereas OSMR
is not expressed in most of CD45-positive cells (20). In the thymus, OSMR
expression was detected from fetus to adult (21). Expression of OSM by the lck proximal promoter in transgenic mice resulted in thymic hypertrophy, extrathymic T cell development, and autoimmune disease-like symptoms (22, 23). These results suggest that OSM may play a role for thymic environment.
Most T cells are eliminated during development by apoptosis, while apoptotic T cells are hardly found in the normal thymus, indicating that they must be eliminated quickly by scavengers in the thymus. We recently found a novel class of thymic macrophages with CD4, which exhibit strong phagocytic activity, suggesting that the CD4+ macrophages are involved in the T selection by eliminating apoptotic T cells (24). However, the origin and nature of CD4+ macrophages in the thymus remain unexplored. In this report, we demonstrate that a subpopulation of TECs with OSMR as well as the OSM-responsive TEC line (ORTEC), but not soluble factors, induce the development of CD4+ macrophage from intrathymic lymphoid progenitors in an IL-7-dependent manner.
| Materials and Methods |
|---|
|
|
|---|
Timed pregnant C57BL/6 mice were purchased from Nihon SLC (Hamamatsu, Japan). gp130D/D mice used in this paper were backcrossed with C57BL/6 eight times. The time at midday was taken to be E0.5 for the plugged mice. All mice were housed in specific-pathogen-free barrier animal facilities. All experiments were performed according to our institutional guidelines.
Generation of mAb against murine OSMR (mOSMR)
Wistar rats (Nihon SLC) were immunized with recombinant soluble mOSMR by the standard immunization procedure (25). Lymph nodes were dissociated and fused with mouse myeloma P3X cells as previously described (26), and hybridoma supernatants were screened for the production of anti-mOSMR specific Abs by flow cytometry. Anti-mOSMR Ab (E26-2A8) was selected and was produced in nude mice. The isotype of anti-mOSMR Ab was determined as IgG1 by using the rat IgG isotyping kit (Serotec, Oxford, U.K.).
Flow cytometry and cell sorting
Cells suspended in PBS were pretreated with blocking Ab against the Fc
R (FcR, 2.4G2) for 30 min on ice to eliminate nonspecific binding. They were then incubated with primary Abs or appropriate isotype-matched control Abs. Primary Abs used were FITC-conjugated anti-murine CD11b (FITC-CD11b), FITC-CD11c, FITC-CD40, FITC-CD44, FITC-CD80, FITC-CD86, FITC-ICAM PE-conjugated CD11b (PE-CD11b), PE-CD11c, PE-MHC class II, biotinylated anti-murine CD4 (biotin-CD4), biotin-CD11b, biotin-CD25, biotin-CD45 (all from BD Pharmingen, San Diego, CA), and FITC-F4/80 (BioSource International, Camarillo, CA). After 30 min of incubation, cells were washed with PBS. Cells were then incubated with streptavidin-allophycocyanin (Molecular Probes, Eugene, OR) for 30 min on ice and washed with PBS. After washing, cells were resuspended in 500 µl of PBS with propidium iodine and analyzed by FACSCalibur (BD Biosciences, San Jose, CA). Dead cells were excluded by propidium iodine staining.
Primary TECs and establishment of ORTEC
E19 fetal thymi were disaggregated by treatment with collagenase and trypsin and filtered through a 40-µm mesh. The recovered fetal thymic cells were resuspended in the culture medium composed of RPMI 1640 supplemented with 10% FBS, 50 µM 2-ME, and gentamicin sulfate, and were inoculated onto six-well culture plates (4 x 106 cells/well) in the presence of 10 ng/ml OSM (R&D Systems, Minneapolis, MN). After a few days, floating cells were removed by washing with PBS. Adherent cells were analyzed after 1 wk of culture. For coculture experiments, primary TECs cultured for 1014 days were used. To establish the cell line, ORTEC, primary TECs were maintained for 2 mo in the presence of OSM, and growing cells were cloned by a cloning cup.
Culture of fetal thymocytes
Thymocytes isolated from E14.5 fetal thymi were cultured under various conditions. In coculture experiments, thymocytes were cultured with semiconfluent ORTEC in the presence of OSM, stem cell factor (SCF; provided by Kirin, Takasaki, Japan) and IL-7 (PeproTech, Rocky Hill, NJ). The culture medium used was RPMI 1640 supplemented with 10% FBS, 50 µM 2-ME and gentamicin sulfate (the standard culture medium). After 4 days, both floating and adherent cell numbers were determined, and the surface phenotype of these cells was analyzed by flow cytometry. Adherent cells were harvested by trypsin treatment and were filtered through a 40-µm mesh. Both floating and adherent cells were analyzed by flow cytometry. To test the requirement of cell-cell contacts, we used a Costar Transwells chamber (0.4-µm pore size, polycarbonate membrane; Costar, Cambridge, MA) to prevent cell-cell contacts. In the case of liquid culture, thymocytes were incubated for 4 days in the presence of conditioned medium of ORTEC or a cytokine mixture as indicated in each experiment.
Preparation of progenitor cells
Cell sorting was performed by FACSVantage SE (BD Biosciences). For the isolation of CD25/CD44+/FcR+ cells, thymocytes without pretreatment with blocking Ab were incubated with FITC-FcR, PE-CD25, and biotin-CD44. Hemopoietic stem cells were isolated basically according to previous reports (12, 27, 28). Briefly, bone marrow and fetal liver cells were incubated with unconjugated rat Abs specific for lineage (Lin) markers (CD4, CD8, CD11b, Gr-1, B220, TER119). Lin+ cells were partially removed with sheep anti-rat IgG-conjugated immunomagnetic beads. Remaining cells were stained with FITC-ScaI and PE-c-Kit Abs. ScaI/c-Kit DP cells were used as hemopoietic stem cells fractions.
RT-PCR
RNA was prepared by using the Fast Track kit (Invitrogen Life Technologies, Carlsbad, CA) or the RNeasy kit (Qiagen, Valencia, CA). According to the manufacturers protocol, RNA was reverse-transcribed using the first strand cDNA synthesis kit (Pharmacia, Peapack, NJ). PCR was performed using various sets of primers listed in Table I. After incubation for 5 min at 94°C, PCR amplification was performed using the GeneAmp PCR system (PerkinElmer, Wellesley, MA) under the following conditions: denaturation at 94°C for 30 s; annealing at 54°C, 56°C, or 60°C for 30 s; elongation at 72°C for 45 s. The amplified PCR products were electrophoresed on a 2% agarose gel and visualized with ethidium bromide. GAPDH was used as an internal control.
|
CD4/CD11b+ cells and CD4+/CD11b+ cells were isolated from E14.5 thymus by FACSVantage. Cocultured cells were sorted by CD4 expression with FACSVantage. The cells were plated in parmanox chamber slides (Nalge Nunc) and incubated at 37°C for 2 h. For induction of apoptosis, thymocytes were incubated at 37°C for 12 h with 107 M dexamethasone in the standard culture medium. Apoptosis was confirmed by TUNEL and Annexin V staining (data not shown). After 12 h, thymocytes were incubated with 100 ng/ml 4',6'-diamidino-2-phenylindole (DAPI) for 15 min at 4°C. These cells were used for phagocytosis assay. Apoptotic thymocytes (4 x 106 cells) were added to macrophages on chamber slides. After incubation, cells were extensively washed three times. The cells were then fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, followed by three washes with PBS. After fixation, macrophages were stained with PE-conjugated CD11b. Phagocytosis was evaluated by microscopic observation.
Immunostaining of cultured cells
The Abs used were: anti-keratin 5 (Babco, Richmond, CA), biotin-UEA1, and isotype-matched Abs as negative controls for the first Abs. Troma-1, rat anti-keratin 8 mAb, was kindly provided by Dr. R. Kemler (Max-Planck Institute of Immunobiology, Freiburg, Germany). Cultured cells were fixed with 4% paraformaldehyde in PBS and stained with Abs; incubated with HRP-conjugated anti-rat, anti-rabbit IgG, or HRP-conjugated streptavidin; and visualized by diaminobenzidine.
| Results |
|---|
|
|
|---|
As it was recently reported that E14.5 thymocytes give rise to CD11b+ cells in the presence of M-CSF, IL-6, and IL-7 (14), we cultured E14.5 thymocytes in the presence of these cytokines to test whether thymocytes give rise to CD4+ macrophages. Although CD11b+ cells were generated by these cytokines as reported previously, they never expressed CD4 (Fig. 1). Therefore, we suspected that the development of CD4+ macrophages might be supported by the thymic environment, but not soluble factors alone. OSM is abundantly expressed in the thymus (Fig. 2A) and OSMR is expressed at the periphery of medulla but not in the thymocytes (21), suggesting that OSM may play a role for thymic environment. As it is believed that thymic selection occurs in this area, we considered the possibility that TECs at the periphery of medulla might play a role for the development of CD4+ macrophages.
|
|
To characterize ORTEC, flow cytometric analysis was performed. As expected, they expressed OSMR
as well as gp130, the common receptor subunit of the IL-6 family cytokines (Fig. 3A). ORTEC did not express mature endothelial markers such as tyrosine kinase with Ig and epidermal growth factor homology domains (TIE)-1, TIE-2, and PECAM, suggesting that ORTEC cells are not endothelial cells (Fig. 3A). To further characterize ORTEC, we used macroarray analysis using 1000 known genes, and found that ORTEC expressed various epithelial genes such as cadherin-6, cadherin-11, cadherin-13, and
-catenin. ORTEC also expressed CD29, CD49C, CD104, and connexin-43 (data not shown), which were reported to be expressed in TECs (29). MHC class II was also expressed in ORTEC at a low level (data not shown). It is known that TECs in cortex and medulla can be distinguished by the expression of keratins, i.e., keratin 5 is expressed in medulla, whereas keratin 8 is expressed in cortex (15). Immunostaining indicated that ORTEC expressed keratin 5 but not keratin 8 (Fig. 3B). In addition, expression of UEA-1, a marker for the thymic core medullary epithelium (30), was not detected in ORTEC (Fig. 3D). These results suggest that ORTEC represent epithelial cells at the periphery of medullar.
|
We performed coculture experiments of immature thymocytes with TECs. We cocultured E14.5 thymocytes in the presence of SCF, IL-7, and OSM with primary TECs that had been grown in the presence or absence of OSM. CD4+/CD11b+ cells vigorously proliferated in the presence of primary TECs that had been grown in the presence of OSM. In contrast, production of CD4+/CD11b+ cells was less effective in the coculture with primary TECs that had been grown without OSM (Fig. 4A). To uncover the role of OSM in the development of CD4+ macrophages in vivo, we analyzed gp130D/D thymi. OSM manifests its functions through the receptor consisting of OSMR
and gp130. As gp130D/D mutant lacks its entire cytoplasmic domain, the mutant mice fail to respond to OSM. The population of CD4+/CD11b+ cells in gp130D/D thymus was smaller than that of the wild-type littermates (Fig. 4B, upper panel), although it was reported that the development of T cell progenitors was not affected in the gp130D/D mice (31). The ratio of CD4+/CD11b+ cells to the total CD11b+ cells was significantly reduced in gp130D/D thymus (Fig. 4B, lower panel). This supports the possibility that OSM plays a role for the development of CD4+/CD11b+ cells.
|
|
|
Conditioned medium of ORTEC failed to induce CD4+/CD11b+ cells from thymocytes, whereas it induced the development of CD4/CD11b+ cells (Fig. 7A). The production of CD4+/CD11b+ cells was not induced when the direct interaction between thymocytes and ORTEC was prevented by using a Transwell chamber (Fig. 7A). RT-PCR analysis revealed that ORTEC expressed mRNA for IL-1
, IL-6, M-CSF, and SCF (Fig. 7B), suggesting that CD4+ macrophages were not induced by these cytokines (see also Fig. 1). It is thus strongly suggested that a direct interaction between thymocytes and ORTEC is required for the development of CD4+ macrophages.
|
|
E14.5 DN thymocytes can be separated into two populations based on the expression of CD25 and CD44, and the CD25/CD44+ thymocytes are the most immature T cell progenitors in the thymus. While it was also reported that CD25/CD44+ cells gave rise to macrophages in the presence of M-CSF, IL-6, and IL-7 (14), the CD25/CD44+ cells in fetal thymus were heterogeneous and contained both lymphoid and myeloid precursors (32). It was shown that the FcR+ subpopulation of the CD25/CD44+ cells is comprised of almost exclusively T cell progenitors and contamination of myeloid progenitors is minimum (32). Therefore, we isolated the CD25/CD44+/FcR+ population from E14.5 thymus and examined their differentiation in the presence of ORTEC. As shown in Fig. 9, CD4+/CD11b+ cells were generated from this population by coculture with ORTEC. While CD11b+ cells were developed from CD25/CD44+/FcR+ thymocytes by a mixture of cytokinesOSM, SCF, M-CSF, IL-6, and IL-7they were negative for CD4, highlighting the difference between CD4+/CD11b+ cells and CD4/CD11b+ cells. In addition, the generation of CD4+/CD11b+ cells was completely dependent on IL-7 (Fig. 9), an essential cytokine for T cell development by maintaining survival of T cell precursors (19, 33). In the absence of IL-7, almost all CD25/CD44+/FcR+ cells died during 4 days of culture, while only a small number of CD11b+ cells were found. These results indicate that CD4+/CD11b+ cells are generated directly from CD25/CD44+/FcR+ thymocytes, but not as a result of expansion of a small population of CD11b+ cells. Collectively, the IL-7 dependency also strongly supports that CD4+/CD11b+ cells are generated from the intrathymic lymphoid progenitors.
|
) fraction were isolated and cocultured with ORTEC. HSCs and Mo/M
from bone marrow did not proliferate and differentiate into CD4+/CD11b+ cells (Fig. 10, upper panel). HSCs from fetal liver vigorously proliferated, and CD4/CD11b+ cells were induced by this coculture. Although a small number of CD4+/CD11b+ cells were detected in the coculture of fetal liver HSCs, the induction efficiency of CD4+/CD11b+ cells was much lower than that from intrathymic lymphoid progenitors (Fig. 10, lower panel). Taken together, it is suggested that thymic CD4+ macrophages are not derived from the myeloid and multipotent progenitors.
|
| Discussion |
|---|
|
|
|---|
M-CSF is known as a primary regulator of macrophage production. However, Cecchini et al. (34) reported that macrophages were present in the thymus of op/op mouse, which lacks M-CSF due to an inactivating mutation in the M-CSF gene. Lee et al. (14) reported that macrophages were not induced from thymocytes by M-CSF alone, and the combination of M-CSF/IL-6 induced significant induction of macrophages. Consistent with their results, some CD4/CD11b+ cells were generated from CD25/CD44+/FcR+ thymocytes in the presence of M-CSF and IL-6 (Fig. 9). We also demonstrated that the population of CD4/CD11b+ cells was not reduced by the lack of gp130 signals (Fig. 4B), suggesting that the IL-6 family of cytokines are not essential for the development of CD4 macrophages in the thymus. However, a mixture of cytokines as well as conditioned medium of ORTEC, both of which contained M-CSF and IL-6, failed to induce CD4+/CD11b+ cells, highlighting a difference between CD4/CD11b+ cells and CD4+/CD11b+ cells. In contrast to the development of CD4/CD11b+ cells that is induced by soluble factors, development of CD4+/CD11b+ cells requires the cell-cell contacts between thymocytes and ORTEC. To understand the mechanism underlying the development of CD4+ macrophage, it is necessary to identify the molecules responsible for the conversion of thymocytes to macrophages. Attempts to find such molecules are currently underway.
Our results indicate that CD4+ macrophages are derived from the most immature thymocytes with the CD25/CD44+/FcR+ phenotype in an IL-7-dependent manner. The frequency of macrophages generated from CD25/CD44+/FcR+ thymocytes was dramatically increased by the addition of IL-7, a cytokine that delivers survival signals for lymphoid cells (33, 35). Although CD25/CD44+/FcR+ thymocytes may be still heterogeneous (32), IL-7 dependency of the CD4+ macrophage development strongly suggests lymphoid progenitors as the origin of such macrophages in the thymus. Myeloid (Mo/M
) progenitors in bone marrow failed to differentiate into CD4+ macrophages by coculture with ORTEC (Fig. 10). In contrast, a small number of CD4+/CD11b+ cells were generated from fetal liver HSCs. As the HSC fraction from fetal liver includes lymphoid- as well as myeloid-restricted progenitors and multipotent stem cells are not present in fetal thymus (36), it is likely that lymphoid-restricted progenitors in the HSC fraction differentiated into CD4+ macrophages by coculture with ORTEC. Taken together, it is concluded that CD4+ macrophages are derived from intrathymic lymphoid progenitors but not from other progenitors.
Although heterogeneity of TECs has been known, little is known about the characteristics of TECs. In fact, only a few Ags have been known to distinguish between cortex and medullar epithelial cells. Hence it has been difficult to study the characteristics of each subset of TECs. We found that OSM stimulates the proliferation of TECs in the primary culture of fetal thymic cells and established the OSM-dependent cell line ORTEC that expressed various epithelial markers together with OSMR. A cell population that expressed OSMR was readily found in thymic cells by flow cytometry (data not shown). While these sorted OSMR+ cells survived, they did not proliferate in the presence of OSM alone, suggesting that they require additional factors that are presumably provided by cells in the primary culture. As OSMR was not expressed on thymocytes and CD4+/CD11b+ cells, the effect of OSM on the development of these cells was considered to be indirect (Fig. 8B). Therefore, it is most likely that OSM regulates the development of CD4+ macrophages through the thymic environment. Consistently, ORTEC, as well as primary TECs cultured in the presence of OSM supported the development of CD4+ macrophages from immature thymocytes. Moreover, in gp130D/D thymus, the population of CD4+/CD11b+ cells was significantly reduced compared with CD4/CD11b+ cells (Fig. 4B) and our preliminary results using OSM-deficient mice also show similar phenotype (data not shown). The results strongly suggest that OSMR+ TECs play an important role for the differentiation of thymocytes by modulating the generation of CD4+ macrophages in the thymus. A conditional knockout mouse of the STAT3 gene using the CRE recombinase driven by the keratin 5 promoter exhibited severe thymic hypoplasia and alterations in the cortical epithelial cell architecture. Moreover, many apoptotic thymocytes were found in the thymus of knockout mice (37). Keratin 5 is expressed in the majority of TECs in the medulla and cortico-medullary junction and is also expressed in ORTEC. STAT3 is a major mediator of OSM signals and defective OSM signaling in the conditional knockout mice may lead to hypoplasia of TECs, which impairs the development of CD4+ macrophages and thymic DCs. These results strongly support our hypothesis that the normal TECs are involved in the development of DC and CD4+ macrophage, which play roles for the T cell selection and for the clearance of apoptotic T cells in the thymus.
Understanding the T cell development requires not only studies on T cells but also characterization of cells contributing to their environment, i.e., macrophages, DCs and TECs. Our results indicate that a novel class of CD4+ macrophages is generated from intrathymic lymphoid progenitors by the interaction with TECs. To fully understand the development of the immune system, it is important to uncover the cellular network formed by those cells in the thymus.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 This work was supported in part by Grants-in-Aid for Scientific Research and Special Coordination Funds from the Ministry of Education, Culture, Sports, Science and Technology of Japan. ![]()
2 Address correspondence and reprint requests to Dr. Atsushi Miyajima, Institute of Molecular and Cellular Biosciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan. E-mail address: miyajima{at}ims.u-tokyo.ac.jp ![]()
3 Abbreviations used in this paper: DN, double negative; DP, double positive; OSM, oncostatin M; SCF, stem cell factor; TEC, thymic epithelial cell; ORTEC, OSM-responsive TEC line; DAPI, 4',6'-diamidino-2-phenylindole; HSC, hemopoietic stem cell; mOSMR, murine OSMR; Lin, lineage; Mo/M
, monocytes/macrophage; TIE, tyrosine kinase with Ig and epidermal growth factor homology domains. ![]()
Received for publication April 12, 2004. Accepted for publication August 2, 2004.
| References |
|---|
|
|
|---|
in mice. Mech. Dev. 115:127.[Medline]
-chain-deficient mice. Immunity 7:155.[Medline]
This article has been cited by other articles:
![]() |
S. A. Greenberg Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications Neurology, November 20, 2007; 69(21): 2008 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ito, E. Esashi, T. Akiyama, J.-i. Inoue, and A. Miyajima IL-18 produced by thymic epithelial cells induces development of dendritic cells with CD11b in the fetal thymus Int. Immunol., August 1, 2006; 18(8): 1253 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Greenberg, E. M. Bradshaw, J. L. Pinkus, G. S. Pinkus, T. Burleson, B. Due, L. S. Bregoli, K. C. O'Connor, and A. A. Amato Plasma cells in muscle in inclusion body myositis and polymyositis Neurology, December 13, 2005; 65(11): 1782 - 1787. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |